Lazard World Dividend & Income Fund, Inc. (LOR): Christopher Snively , CFO of Lazard World Dividend & Income Fund, Inc. purchased 500 shares on May 11, 2016. The Insider buying transaction was reported by the company on May 12, 2016 to the Securities and Exchange Commission. The shares were purchased at $9.05 per share for a total value of $4,525.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Oct 13, 2015, Patrick Martin Ryan (other) purchased 5,000 shares at $9.97 per share price.
Lazard World Dividend & Income Fund Inc: On Tuesday, May 10, 2016 heightened volatility was witnessed in Lazard World Dividend & Income Fund Inc which led to swings in the share price. The shares opened for trading at $9.05 and hit $9.05 on the upside , eventually ending the session at $9.02, with a gain of 0.75% or 0.0674 points. The heightened volatility saw the trading volume jump to 46,526 shares. The 52-week high of the share price is $12.77 and the company has a market cap of $59 M . The 52-week low of the share price is at $7.31.
Lazard World Dividend & Income Fund Inc. (the Fund) is a diversified closed-end management investment company. The Fund’s investment objective is total return through a combination of dividends income and capital appreciation. The Fund’s world equity portfolio is typically invested in 60 to 90 securities broadly diversified in both developed and emerging market countries and across the capitalization spectrum. The Fund’s invests in automotive; banking; construction and engineering; energy services; financial services; household and personal products; leisure and entertainment; insurance; pharmaceutical and biotechnology; real estate; technology hardware; telecommunications; commercial services and transportation among others. The other sectors in the portfolio include consumer discretionary consumer staples health care industrials materials and utilities. The Fund’s Investment Manager is Lazard Asset Management LLC (Lazard).